Virtual Screening Discovery of New Acetylcholinesterase Inhibitors Issued from CERMN Chemical Library

In our quest to find new inhibitors able to inhibit acetylcholinesterase (AChE) and, at the same time, to protect neurons from beta amyloid toxicity, i.e., inhibitors interacting with the catalytic anionic subsite as well as with the peripherical anionic site of AChE, a virtual screening of the Centre d'Etudes et de Recherche sur le Medicament de Normandie (CERMN) chemical library was carried out. Two complementary approaches were applied, i.e., a ligand- and a structure-based screening. Each screening led to the selection of different compounds, but only two were present in both screening results. In vitro tests on AChE showed that one of those compounds presented a very good inhibition activity, of the same order as Donepezil. This result shows the real complementary of both methods for the discovery of new ligands.

[1]  A. Goldman,et al.  Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein , 1991, Science.

[2]  Yuan-Ping Pang,et al.  Crystal packing mediates enantioselective ligand recognition at the peripheral site of acetylcholinesterase. , 2005, Journal of the American Chemical Society.

[3]  Patrice Gouet,et al.  ESPript: analysis of multiple sequence alignments in PostScript , 1999, Bioinform..

[4]  I B WILSON,et al.  The inhibitory effect of stilbamidine, curare and related compounds and its relationship to the active groups of acetylcholine esterase; action of stilbamidine upon nerve impulse conduction. , 1950, Biochimica et biophysica acta.

[5]  P. Watkins,et al.  Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease. , 1994, JAMA.

[6]  N. Inestrosa,et al.  Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils. , 1997, Journal of molecular biology.

[7]  J L Sussman,et al.  Structure of acetylcholinesterase complexed with (−)‐galanthamine at 2.3 Å resolution , 1999, FEBS letters.

[8]  Thierry Langer,et al.  Acetylcholinesterase inhibitory activity of scopolin and scopoletin discovered by virtual screening of natural products. , 2004, Journal of medicinal chemistry.

[9]  R. Glen,et al.  Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. , 1995, Journal of molecular biology.

[10]  A J Hopfinger,et al.  The rationale for E2020 as a potent acetylcholinesterase inhibitor. , 1996, Bioorganic & medicinal chemistry.

[11]  Jana Sopkova-de Oliveira Santos,et al.  Synthesis and biological evaluation as AChE inhibitors of new indanones and thiaindanones related to donepezil. , 2005, European journal of medicinal chemistry.

[12]  R. Bartus,et al.  The cholinergic hypothesis of geriatric memory dysfunction. , 1982, Science.

[13]  T Nakamura,et al.  Novel piperidine derivatives. Synthesis and anti-acetylcholinesterase activity of 1-benzyl-4-[2-(N-benzoylamino)ethyl]piperidine derivatives. , 1990, Journal of medicinal chemistry.

[14]  J. Sussman,et al.  Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs. , 1999, Structure.

[15]  D Lamba,et al.  Three‐dimensional structure of a complex of galanthamine (Nivalin®) with acetylcholinesterase from Torpedo californica: Implications for the design of new anti‐Alzheimer drugs , 2001, Proteins.

[16]  A. Cavalli,et al.  Synthesis and screening for antiacetylcholinesterase activity of (1-benzyl-4-oxopiperidin-3-ylidene)methylindoles and -pyrroles related to donepezil. , 2001, Journal of medicinal chemistry.

[17]  J L Sussman,et al.  Kinetic and structural studies on the interaction of cholinesterases with the anti-Alzheimer drug rivastigmine. , 2002, Biochemistry.

[18]  P Willett,et al.  Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.

[19]  L. Austin,et al.  Two selective inhibitors of cholinesterase. , 1953, The Biochemical journal.

[20]  Yuan-Ping Pang,et al.  Acetylcholinesterase complexed with bivalent ligands related to huperzine a: experimental evidence for species-dependent protein-ligand complementarity. , 2003, Journal of the American Chemical Society.

[21]  B. P. Doctor,et al.  Stable Complexes Involving Acetylcholinesterase and Amyloid-β Peptide Change the Biochemical Properties of the Enzyme and Increase the Neurotoxicity of Alzheimer’s Fibrils , 1998, The Journal of Neuroscience.

[22]  M Briley,et al.  Novel [2-(4-piperidinyl)ethyl](thio)ureas: synthesis and antiacetylcholinesterase activity. , 1994, Journal of medicinal chemistry.

[23]  A M LANDS,et al.  An investigation of the structure-activity correlations within a series of ambenonium analogs. , 1958, The Journal of pharmacology and experimental therapeutics.

[24]  H. Sugimoto,et al.  Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-(2-phthalimidoethyl)piperidine and related derivatives. , 1992, Journal of medicinal chemistry.

[25]  F. Diederich,et al.  Interactions with aromatic rings in chemical and biological recognition. , 2003, Angewandte Chemie.

[26]  I Silman,et al.  A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation. , 2001, Biochemistry.

[27]  S. Nightingale,et al.  From the Food and Drug administration. , 1990, JAMA.

[28]  J L Sussman,et al.  Structure and dynamics of the active site gorge of acetylcholinesterase: Synergistic use of molecular dynamics simulation and X‐ray crystallography , 1994, Protein science : a publication of the Protein Society.

[29]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.